Endo Pharmaceuticals Financial Statements
Endo Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Endo Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,085.6 | 909.7 | 820.2 |
| Gross Profit ($ mil.) | 868.2 | 708.2 | 633.8 |
| Operating Income ($ mil.) | 317.2 | 210.5 | 313.3 |
| Total Net Income ($ mil.) | 227.4 | 137.8 | 202.3 |
| Diluted EPS (Net Income) | 1.69 | 1.03 | 1.52 |
Endo Pharmaceuticals Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 306.2 | 290.3 | 304.6 |
| Gross Profit ($ mil.) | 243.2 | 233.7 | 238.8 |
| Operating Income ($ mil.) | 82.1 | 85.2 | 67.6 |
| Total Net Income ($ mil.) | 59.0 | 59.5 | 50.6 |
| Diluted EPS (Net Income) | 0.48 | 0.44 | 0.38 |
Endo Pharmaceuticals Stock Quote & Chart
10/13/08 15:00:29 EST •
NASDAQ •
16.91
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Endo Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.34 | 3.50 | 1.54 |
| Price/Earnings Ratio | 13.06 | 15.38 | 15.76 |
| Price/Book Ratio | 2.73 | 2.94 | 1.49 |
| Price/Cash Flow Ratio | 9.64 | 12.49 | 9.63 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Endo Pharmaceuticals Financial Ratios
Endo Pharmaceuticals Competitive Intelligence
| Abbott Labs | Pfizer | Purdue Pharma | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 48,418.0 | 1,400.0 |
| Employees | 68,000 | 86,600 | 2,200 |
| Market Cap ($ mil.) | 88,531.0 | 129,224.9 | -- |
Competitive Landscape
